Gleb Kuznetsov is the founder of Manifold Bio. Manifold Bio has raised $100M in total funding. Latest round: Growth. Backed by Roche. Based in Boston, MA.
Gleb Kuznetsov, PhD, is the Co-Founder and CEO of Manifold Bio, a platform biotechnology company pioneering AI-guided protein design and mega-scale in vivo screening to develop tissue-targeted medicines. He founded the company after completing his PhD in the Harvard Biophysics program in George Church's lab, where he developed new approaches for protein measurement and design using high-throughput biology and machine learning. Kuznetsov left a career in tech to address bottlenecks in in vivo drug discovery, combining AI-guided design with large-scale in vivo testing to create targeted biologics at unprecedented scale.
Full founder directory · Investor directory · Company funding database · Fundraising library